Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 0 | 0 | 0 | 512 | 38 |
| Gross Profit | N/A | N/A | N/A | 512 | 38 |
| Operating Expenses | 6,077 | 5,909 | 6,428 | 5,408 | 6,901 |
| Operating Income | -6,077 | -5,909 | -6,428 | -4,896 | -6,863 |
| Interest Expense | 232 | 261 | 282 | 283 | 282 |
| Other Income | 40 | 37 | 27 | 26 | 20 |
| Pre-tax Income | -6,269 | -6,133 | -6,683 | -5,153 | -7,125 |
| Net Income Continuous | -6,269 | -6,133 | -6,683 | -5,153 | -7,125 |
| Net Income | $-6,269 | $-6,133 | $-6,683 | $-5,153 | $-7,125 |
| EPS Basic Total Ops | -0.24 | -0.23 | -0.28 | -0.21 | -0.32 |
| EPS Basic Continuous Ops | -0.24 | -0.23 | -0.28 | -0.21 | -0.32 |
| EPS Diluted Total Ops | -0.24 | -0.23 | -0.28 | -0.21 | -0.32 |
| EPS Diluted Continuous Ops | -0.24 | -0.23 | -0.28 | -0.21 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.23 | -0.28 | -0.22 | -0.32 |
| EBITDA(a) | $-6,026 | $-5,852 | $-6,369 | $-4,834 | $-6,805 |